Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.
Discover how emotional intelligence transforms leadership and fosters resilience in a fast-paced world. Listen to the episode for insights.
Weaver helps a health system evaluate its revenue quality, estimate collections and gain clarity on complex streams.
Leadership coaching helps executives perform with clarity, confidence and impact, especially during times of rapid change and uncertainty.
Successful companies invest in leaders. WeaverLEAD is a coach training program grounded in ICF principles for professionals ready to elevate others.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
Our Health Care Valuation Insights Hub is your go-to resource for knowledge and strategies to stay ahead in an evolving industry.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
See how ambulatory surgery centers (ASC) and imaging center valuation multiples compare, revealing key differences, patterns and transaction risk.
Explore why profitable hospitals command higher valuations and how variability in transaction databases impacts fair market value.
Explore how proposed Medicaid cuts could impact health care valuations, reimbursement models and financial stability across various provider segments.